{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:31:34Z","timestamp":1791585094008,"version":"4.3.4"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["UH3FD006795"],"award-info":[{"award-number":["UH3FD006795"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The coronavirus disease 2019 (COVID\u201019) pandemic is an ongoing global health crisis that has had a range of impacts on people living with migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Qualitative interviews performed as part of the Migraine Clinical Outcome Assessment System project, a multi\u2010stage Food and Drug Administration\u2013grant funded program to develop a patient\u2010centered core set of outcome measures for use in migraine clinical trials, offered an opportunity to explore the experience of living with migraine during the pandemic as well as to examine whether migraine treatment priorities, symptoms, and associated disability changed due to the pandemic. Semi\u2010structured interviews were conducted in the United States between the summer and fall of 2020 with 40 individuals with self\u2010reported, medically diagnosed migraine who self\u2010reported that they had not tested positive for or been diagnosed with COVID\u201019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy percent (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a028) of the sample reported \u22651 pandemic\u2010related impact on their life with migraine. Fourteen participants reported both positive and negative impacts, twelve reported negative impacts only, and two reported positive impacts only. Among those reporting \u22651 pandemic\u2010related impact, nine participants (32%) reported more frequent and five (17%) reported less frequent migraine attacks. Other negative impacts included interrupted medical care (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a09; 32%), and greater stress (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a013; 46%). The most frequent positive impact reported was greater access to health care (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a08; 29%). Ictal and interictal symptoms were not noted to change due to the pandemic, but some respondents reported less disability due to increased flexibility of schedules and reduced expectations. Treatment priorities did not change due to the pandemic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global COVID\u201019 pandemic has resulted in both negative and positive impacts for people living with migraine. Lessons to be considered when moving into a post\u2010pandemic world include benefits of and satisfaction with telehealth and the benefits and importance of healthy lifestyle habits and flexibility such as improved sleep, reduced stress, and fewer social expectations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.14274","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T10:24:03Z","timestamp":1647426243000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of the COVID\u201019 pandemic on people living with migraine: Results of the MiCOAS qualitative study"],"prefix":"10.1111","volume":"62","author":[{"given":"Dawn C.","family":"Buse","sequence":"first","affiliation":[{"name":"Vector Psychometric Group, LLC  Chapel Hill North Carolina USA"},{"name":"Neurology Albert Einstein College of Medicine  Bronx New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya T.","family":"Gerstein","sequence":"additional","affiliation":[{"name":"Patient Centered Outcomes Open Health Group  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie R.","family":"Houts","sequence":"additional","affiliation":[{"name":"Vector Psychometric Group, LLC  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"McGinley","sequence":"additional","affiliation":[{"name":"Vector Psychometric Group, LLC  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa A.","family":"Uzumcu","sequence":"additional","affiliation":[{"name":"Patient Centered Outcomes Open Health Group  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly P.","family":"McCarrier","sequence":"additional","affiliation":[{"name":"Patient Centered Outcomes Open Health Group  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Cooke","sequence":"additional","affiliation":[{"name":"Patient Centered Outcomes Open Health Group  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Touba","sequence":"additional","affiliation":[{"name":"Patient Centered Outcomes Open Health Group  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy K.","family":"Nishida","sequence":"additional","affiliation":[{"name":"Vector Psychometric Group, LLC  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Wirth","sequence":"additional","affiliation":[{"name":"Vector Psychometric Group, LLC  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Neurology Albert Einstein College of Medicine  Bronx New York USA"},{"name":"Headache Montefiore Medical Center  Bronx New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"issue":"14","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2020.3072","article-title":"COVID\u201019\u2010new insights on a rapidly changing epidemic","volume":"323","author":"Del Rio C","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/head.13810","article-title":"Migraine care in the era of COVID\u201019: clinical pearls and plea to insurers","volume":"60","author":"Szperka CL","year":"2020","journal-title":"Headache"},{"issue":"4","key":"e_1_2_10_4_1","first-page":"233","article-title":"Management of neurological care during the COVID\u201019 pandemic","volume":"35","author":"Mat\u00edas\u2010Guiu J","year":"2020","journal-title":"Neurologia (Engl Ed)"},{"issue":"1","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.4103\/aian.AIAN_296_20","article-title":"Managing migraine in the times of COVID\u201019 pandemic","volume":"23","author":"Chowdhury D","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"issue":"2","key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(06)70348-9","article-title":"Chronic disorders with episodic manifestations: focus on epilepsy and migraine","volume":"5","author":"Haut SR","year":"2006","journal-title":"Lancet Neurol"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"issue":"1","key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","article-title":"Impact of coronavirus disease 2019 (COVID\u201019) pandemic on patients with migraine: a web\u2010based survey study","volume":"21","author":"Al\u2010Hashel JY","year":"2020","journal-title":"J Headache Pain"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa449"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072\u2010021\u201005180\u20108"},{"issue":"1","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12883-021-02378-3","article-title":"Impact of COVID\u201019 pandemic on migraine management in the United States: insights from migraine tracking app users","volume":"21","author":"Kato Y","year":"2021","journal-title":"BMC Neurol"},{"key":"e_1_2_10_12_1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.579047","article-title":"Migraine symptoms improvement during the COVID\u201019 lockdown in a cohort of children and adolescents","volume":"11","author":"Dallavalle G","year":"2020","journal-title":"Front Neurol"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.597881","article-title":"Investigating the effects of COVID\u201019 quarantine in migraine: an observational cross\u2010sectional study from the Italian National Headache Registry (RICe)","volume":"11","author":"Delussi M","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","article-title":"A self\u2010administered screener for migraine in primary care: the ID migraine validation study","volume":"61","author":"Lipton RB","year":"2003","journal-title":"Neurology"},{"issue":"17","key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1001\/jama.2008.570","article-title":"The CAGE questionnaire for detection of alcoholism","volume":"300","author":"O\u2019Brien CP","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jval.2017.11.014","article-title":"Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development","volume":"21","author":"Turner\u2010Bowker DM","year":"2018","journal-title":"Value Health"},{"issue":"7","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1007.030703","article-title":"SARS control and psychological effects of quarantine, Toronto, Canada","volume":"10","author":"Hawryluck L","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"10227","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","article-title":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence","volume":"395","author":"Brooks SK","year":"2020","journal-title":"Lancet"},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2017.00148","article-title":"Alexithymia and suicide risk in psychiatric disorders: a mini\u2010review","volume":"8","author":"De Berardis D","year":"2017","journal-title":"Front Psychiatry"},{"issue":"2","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3201\/eid1002.030750","article-title":"Fear and stigma: the epidemic within the SARS outbreak","volume":"10","author":"Person B","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11920-016-0741-y","article-title":"The role of fear\u2010related behaviors in the 2013\u20132016 West Africa Ebola virus disease outbreak","volume":"18","author":"Shultz JM","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"e_1_2_10_22_1","first-page":"1","article-title":"Current and future challenges in the delivery of mental healthcare during COVID\u201019","volume":"11","author":"Gautam M","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"5","key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/head.14110","article-title":"Patient experience of telemedicine for headache care during the COVID\u201019 pandemic: an American Migraine Foundation survey study","volume":"61","author":"Chiang C\u2010C","year":"2021","journal-title":"Headache"},{"issue":"7","key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/head.14150","article-title":"Telehealth as a new care delivery model: the headache provider experience","volume":"61","author":"Minen MT","year":"2021","journal-title":"Headache"},{"issue":"1","key":"e_1_2_10_25_1","first-page":"77","article-title":"Treatment experiences in a high frequency sample of people with migraine: results of the coalition for headache and migraine patients (CHAMP) headache disease patient access survey","volume":"61","author":"Morton BA","year":"2021","journal-title":"Headache"},{"issue":"4","key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.47.4.871","article-title":"Classification of daily and near\u2010daily headaches: field trial of revised IHS criteria","volume":"47","author":"Silberstein SD","year":"1996","journal-title":"Neurology"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.14274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:25:16Z","timestamp":1762089916000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1111\/head.14274"],"URL":"https:\/\/doi.org\/10.1111\/head.14274","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"2021-08-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}